Skip to content
← Childhood Acute Lymphoblastic Leukemia

FOR PATIENTS · SOURCE READING

Targeted therapy

Source: Childhood Acute Lymphoblastic Leukemia (PDQ®)–Patient Version, National Cancer Institute.

Source updated: April 15, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Types of treatment for childhood acute lymphoblastic leukemia

Targeted therapy uses drugs or other substances to block the action of specific enzymes, proteins, or other molecules involved in the growth and spread of cancer cells. Often, targeted therapies are only used in specific ALL subtypes in which the specific target of the drug is present. Targeted therapy used or studied to treat childhood ALL includes:

bortezomib

Source links and citations

dasatinib

Source links and citations

imatinib mesylate

Source links and citations

inotuzumab ozogamicin

Source links and citations

nivolumab

Source links and citations

ruxolitinib

Source links and citations

Learn more about Targeted Therapy to Treat Cancer.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice